Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. ARS Other Annual Report to Security Holders
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. 4 Insider Changes in Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Executive or director change · Regulation FD disclosure
  17. DEL AM Other DEL AM
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. S-3 Offering Registration Statement
  20. 10-K Report Annual Report

Page 21 of 36 · 701 filings